본문 바로가기

Journals

  • Home
  • Cyber Information Center
  • Journals
Journals
Journal Corresponding Author Writer,Title,Journal,Publication;Year;Page:Volume(Impact Factor)
First Author
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer Shin, Dong Hoon
(Anticancer Resistance Branch )

Shin, Dong Hoon
(Anticancer Resistance Branch )
. Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer. EXPERIMENTAL AND MOLECULAR MEDICINE. 2023-10-02; 2023; 55(10):2220~2237. IF 12.8 (2022)
Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: a multicenter retrospective study (KROG 21-10)
()

Moon Sung Ho
(Radiological Science？Branch)
. Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: a multicenter retrospective study (KROG 21-10). RADIOTHERAPY AND ONCOLOGY. 2023-09-30; 2023; 189:109936~. IF 5.7 (2022)
Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea Cho Yu Ri
(Targeted Therapy Branch)

Cho Yu Ri
(Targeted Therapy Branch)
. Real-World Epidemiology, Treatment Patterns, and Disease Burden of Chronic Hepatitis B and HDV Co-Infection in South Korea. INFECTIOUS DISEASES AND THERAPY. 2023-09-28; 2023; 12:2387~2403. IF 5.4 (2022)
Crosstalk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells Kim Jong Heon
(Cancer Molecular Biology Branch)

SEO YOONA
(Cancer Molecular Biology Branch)
. Crosstalk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells. CANCER RESEARCH. 2023-09-25; 2023; 83(22):3693~3709. IF 11.2 (2022)
Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities Kang, Hyun Guy
(Medical Engineering Branch)


()
. Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities. MOLECULES AND CELLS. 2023-09-22; 2023; 46(10):579~588. IF 3.8 (2022)
Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening
()

Choi Sung Yong
(Rare & Pediatric Cancer Branch)
. Clonal evolution of long-term expanding head and neck cancer organoid: Impact on treatment response for personalized therapeutic screening. ORAL ONCOLOGY. 2023-09-21; 2023; 146:106571~. IF 4.8 (2022)
Validation of the International MOGAD Panel proposed criteria Kim Ho Jin
(Department of Neurology)

Kim Ki Hoon
(Department of Neurology)
. Validation of the International MOGAD Panel proposed criteria. MULTIPLE SCLEROSIS JOURNAL. 2023-09-20; 2023; 29(13):1680~1683. IF 5.8 (2022)
Range shift verification in spot scanning proton therapy using gamma electron vertex imaging
()

Kim Sung Hun
(Center for Proton Therapy)
. Range shift verification in spot scanning proton therapy using gamma electron vertex imaging. MEDICAL PHYSICS. 2023-09-18; 2023; 51(3):1985~1996. IF 3.8 (2022)
Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021 Choi Kui son
(Department of Cancer Control and Population Health)

Luu Xuan Quy
(Department of Cancer Control and Population Health)
. Socioeconomic inequality in organized and opportunistic screening for colorectal cancer: results from the Korean National Cancer Screening Survey, 2009-2021. EPIDEMIOLOGY AND HEALTH. 2023-09-17; 2023; 45:e2023086~. IF 3.8 (2022)
Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study Jung So Youn
(Cancer Outcome & Quality Improvement Branch)

Lee Eun Gyeong
(Department of Surgery)
. Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study. FRONTIERS IN ONCOLOGY. 2023-09-14; 2023; 13:1208320~. IF 4.7 (2022)
First page Prev paging 41 42 43 44 45 46 47 48 49 50 next paging last page